Mas, S <br/><br/>
Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: multilocus interaction in the mTOR pathway.  [electronic resource] 

 -  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology  Jan 2015 
 - 51-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7862 
<br/><br/><label>Standard No.: </label>10.1016/j.euroneuro.2014.11.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Adult<br/>Antipsychotic Agents--adverse effects<br/>Basal Ganglia Diseases--chemically induced<br/>Carrier Proteins--genetics<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Membrane Proteins--genetics<br/>Middle Aged<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Psychiatric Status Rating Scales<br/>Regulatory-Associated Protein of mTOR<br/>Reproducibility of Results<br/>Risperidone--adverse effects<br/>Signal Transduction--genetics<br/>TOR Serine-Threonine Kinases--genetics<br/>Transcription Factors--genetics<br/>Young Adult